Skip to Content

Myrbetriq Side Effects

Generic Name: mirabegron

Note: This document contains side effect information about mirabegron. Some of the dosage forms listed on this page may not apply to the brand name Myrbetriq.

In Summary

Common side effects of Myrbetriq include: hypertension. Other side effects include: urinary tract infection. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to mirabegron: oral tablet extended release

Along with its needed effects, mirabegron (the active ingredient contained in Myrbetriq) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking mirabegron:

More common
  • Bladder pain
  • bloody or cloudy urine
  • blurred vision
  • difficult, burning, or painful urination
  • dizziness
  • frequent urge to urinate
  • headache
  • lower back or side pain
  • nervousness
  • pounding in the ears
  • slow, fast, or irregular heartbeat
Rare
  • Blindness
  • decrease in vision
  • eye pain
  • lower abdominal or stomach pain
  • nausea or vomiting
  • pain in the groin or genitals
  • tearing or eyes
Incidence not known
  • Blistering, peeling, or loosening of the skin
  • chills
  • cough
  • decrease in the frequency of urination
  • decrease in urine volume
  • diarrhea
  • difficulty in passing urine (dribbling)
  • itching
  • joint or muscle pain
  • red skin lesions, often with a purple center
  • red, irritated eyes
  • sore throat
  • sores, ulcers, or white spots in the mouth or on the lips
  • unusual tiredness or weakness

Some side effects of mirabegron may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common
  • Abdominal or stomach pain
  • back pain
  • body aches or pain
  • difficulty having a bowel movement (stool)
  • difficulty with breathing
  • difficulty with moving
  • dry mouth
  • ear congestion
  • fever
  • loss of voice
  • muscle aches
  • muscle stiffness
  • sneezing
  • stuffy or runny nose
Rare
  • Acid or sour stomach
  • belching
  • burning feeling in the chest or stomach
  • full or bloated feeling
  • heartburn
  • hives or welts
  • indigestion
  • itching
  • itching or pain of the vagina or genital area
  • pain or tenderness around the eyes and cheekbones
  • pressure in the stomach
  • redness of the skin
  • shortness of breath or troubled breathing
  • skin rash
  • stomach discomfort or upset
  • swelling of the lips
  • tenderness in the stomach area
  • thick, white vaginal discharge with mild or no odor

For Healthcare Professionals

Applies to mirabegron: oral tablet extended release

Cardiovascular

Very common (10% or more): Hypertension (up to 11.3%)
Common (1% to 10%): Tachycardia
Uncommon (0.1% to 1%): Atrial fibrillation, palpitations[Ref]

Dermatologic

Uncommon (0.1% to 1%): Urticaria, rash, pruritus, lip edema, macular rash, papular rash
Rare (less than 0.1%): Leukocytoclastic vasculitis, purpura, angioedema[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, constipation, diarrhea, abdominal pain
Uncommon (0.1% to 1%): Dyspepsia, gastritis, abdominal distension
Rare (less than 0.1%): Lip edema[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection
Uncommon (0.1% to 1%): Nephrolithiasis, bladder pain, cystitis, vaginal infection, vulvovaginal pruritus
Postmarketing reports: Urinary retention[Ref]

Musculoskeletal

Common (1% to 10%): Arthralgia
Uncommon (0.1% to 1%): Joint swelling[Ref]

Nervous system

Common (1% to 10%): Headache, fatigue, dizziness[Ref]

Ocular

Uncommon (0.1% to 1%): Glaucoma, blurred vision, dry eyes
Rare (less than 0.1%): Eyelid edema[Ref]

Oncologic

Rare (less than 0.1%): Prostate cancer[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection, sinusitis, rhinitis[Ref]

Hepatic

Uncommon (0.1% to 1%): Increased ALT, AST, and GGT[Ref]

References

1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp." ([2006]):

2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

3. "Product Information. Myrbetriq (mirabegron)." Astellas Pharma US, Inc, Deerfield, IL.

Some side effects of Myrbetriq may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide